Biotechnology company, Starpharma (ASX:SPL) & (OTCQX:SPHRY):
announced new results demonstrating the high level of protection afforded by the VIRALEZE antiviral nasal spray against the highly infectious SARS-CoV-2 Omicron variant in vivo
Shares up 1.52% on the announcement — has COVID lost its charm?